IGF-1 LR3 Long Arg3 Insulin-Like Growth Factor 1mg
IGF-1 LR3: The Most Potent Anabolic Growth Factor for Muscle Hyperplasia Research
IGF-1 LR3 is an extended-half-life analog of Insulin-Like Growth Factor 1, engineered with an arginine substitution at position 3 and a 13-amino acid N-terminal extension. This structural modification makes it roughly 3x more potent than native IGF-1 and dramatically extends its half-life from minutes to hours.
Secure checkout · Third-party tested · Affiliate link
IGF-1 LR3: The Most Potent Anabolic Growth Factor for Muscle Hyperplasia Research
Insulin-Like Growth Factor 1 (IGF-1) is the primary mediator of growth hormone's anabolic effects — when GH binds to receptors in the liver, it triggers IGF-1 secretion which then signals virtually every cell type to grow and differentiate. The LR3 modification addresses native IGF-1's major limitation: extremely rapid binding to IGF binding proteins (IGFBPs) that inactivate it within minutes. By substituting glutamic acid at position 3 with arginine, the molecule has reduced affinity for IGFBPs, allowing it to remain active in circulation far longer. This makes IGF-1 LR3 the gold standard science tool for studying IGF-1 pathway effects without rapid clearance complications.
IGF-1 LR3 Documented Benefits: 6 Documented Mechanisms
Muscle Hyperplasia — New Cell Creation
Unlike hypertrophy (enlarging existing cells), IGF-1 LR3 studies demonstrate it stimulates satellite cell activation and true muscle hyperplasia — the creation of new muscle fibers — a profound distinction for body composition science.
Fat Mobilization & Lipolysis
IGF-1 signaling activates hormone-sensitive lipase and promotes fatty acid oxidation, with science showing simultaneous muscle gain and fat loss — the "recomposition" effect coveted in body optimization science.
Protein Synthesis Amplification
Through PI3K/Akt/mTOR signaling, IGF-1 LR3 powerfully stimulates protein synthesis machinery, dramatically accelerating amino acid incorporation into new muscle protein.
Anti-Catabolic Muscle Preservation
IGF-1 LR3 inhibits the FOXO transcription factors that activate muscle-wasting proteolytic pathways, protecting lean mass even under conditions of caloric deficit or high cortisol.
Bone Density & Collagen Synthesis
Research shows IGF-1 stimulates osteoblast proliferation, increases bone mineral density, and promotes collagen type I synthesis — benefits that extend to structural aesthetics and injury resistance.
Enhanced IGF Signaling Duration
The LR3 modification provides a half-life of approximately 20–30 hours versus native IGF-1's 12–15 minutes, allowing scientists to study sustained IGF pathway activation in tissue culture and animal models.
How IGF-1 LR3 Works: Molecular Mechanism & Pathway
IGF-1 LR3 binds the IGF-1 receptor (IGF1R) — a receptor tyrosine kinase — triggering autophosphorylation and downstream activation of the PI3K/Akt/mTOR pathway (anabolic and anti-apoptotic) and the Ras/MAPK pathway (proliferative). The mTOR complex 1 (mTORC1) activation by Akt is the critical step for protein synthesis initiation via S6K1 phosphorylation and 4E-BP1 inhibition. The reduced IGFBP affinity of the LR3 variant ensures that a higher fraction of administered peptide remains biologically active at the receptor level.
◈ Key Highlights
- Demonstrated 3× higher biological potency than native IGF-1 in receptor binding studies
- Half-life extended from ~12 minutes (native) to ~20-30 hours (LR3 variant)
- Satellite cell activation confirmed in skeletal muscle fiber studies
- Simultaneous fat oxidation and muscle protein synthesis documented in metabolic science
Ideal For
- Muscle biology and hyperplasia science
- Body recomposition mechanism studies
- IGF signaling pathway investigation
- Anti-catabolic mechanism science
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
